Furthermore, the lncRNA tumor suppressor candidate 8 (TUSC8) can inhibit the evolution of papillary thyroid carcinoma via the miR-190b myosin regulatory light chain interacting protein (MYLIP) axis, which in turn can inhibit breast cancer growth and metastasis (38). This evidence concerns the gene MYLIP and differentiated thyroid carcinoma.